Selvita S.A.
SLV.WAR
| Exchange: | WAR |
| Currency | Polish złoty |
| ISIN: | PLSLVCR00029 |
| LEI: | 25940057WQ9YP5MOQF28 |
| Primary Ticker: | SLV.WAR |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Diagnostics & Research |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, autoimmune/immunology, neurology, respiratory, and other. In addition, the company provides drug development services, including formulation development; CMC analytical support; stability and shelf-life determination; clinical supply/GMP manufacturing; small molecules bioanalysis; drug substance and product; and biologics and biosimilars bioanalysis services. Further, it offers research and development services in the areas of agrochemistry analytical support, and flavor and fragrance chemistry. Selvita S.A. was founded in 2007 and is headquartered in Kraków, Poland. |
| Address: | Hexagon, Kraków, Poland, 30-394 |
| Website: | https://selvita.com |
| Full Time Employees: | 886 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 985687552 |
| Market Capitalization Mln: | 985.68 |
| EBITDA: | 22901000 |
| PE Ratio: | 20.65 |
| Wall Street Target Price: | 72.07 |
| Book Value: | 17.21 |
| Earnings Share: | 2.58 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.14 |
| Operating Margin TTM: | -0.07 |
| Return On Assets TTM: | -0.00 |
| Return On Equity TTM: | 0.16 |
| Revenue TTM: | 329022016 |
| Revenue Per Share TTM: | 17.92 |
| Quarterly Revenue Growth YOY: | -0.09 |
| Gross Profit TTM: | 256059925 |
| Diluted Eps TTM: | 2.58 |
| Quarterly Earnings Growth YOY: | 4.0 |
Valuation
| Trailing PE: | 20.65 |
| Price Sales TTM: | 2.99 |
| Price Book MRQ: | 3.09 |
| Enterprise Value: | 1195821764 |
| Enterprise Value Revenue: | 3.67 |
| Enterprise Value Ebitda: | 11.54 |
Shares
| Shares Outstanding: | 18355500 |
| Shares Float: | 13163995 |
| Percent Insiders: | 21.31 |
| Percent Institutions: | 31.86 |
Technicals
| Beta: | -0.00 |
| 52 Week High: | 73 |
| 52 Week Low: | 50.4 |
| 50 Day MA: | 60.19 |
| 200 Day MA: | 63.54 |
Earnings
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | PLN |
| Eps Actual: | -0.54 |
| Report Date: | 2024-03-31 |
| Date: | 2024-03-31 |
| Currency: | PLN |
| Eps Actual: | -0.11 |
| Report Date: | 2024-03-27 |
| Date: | 2023-12-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | 3.47 |
| Report Date: | 2023-11-15 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.23 |
| Report Date: | 2023-09-27 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.42 |
| Report Date: | 2023-05-31 |
| Date: | 2023-03-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.13 |
| Report Date: | 2023-03-28 |
| Date: | 2022-12-31 |
| Currency: | PLN |
| Eps Actual: | 0.69 |
| Report Date: | 2022-11-09 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.49 |
| Report Date: | 2022-09-06 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.20 |
| Report Date: | 2022-05-30 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | 0.26 |
| Report Date: | 2022-03-31 |
| Date: | 2021-12-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | 0.44 |
| Report Date: | 2021-11-24 |
| Date: | 2021-09-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.12 |
| Report Date: | 2021-09-22 |
| Date: | 2021-06-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | -0.01 |
| Report Date: | 2021-05-26 |
| Date: | 2021-03-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.51 |
| Report Date: | 2021-03-30 |
| Date: | 2020-12-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.26 |
| Report Date: | 2020-11-24 |
| Date: | 2020-09-30 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.24 |
| Report Date: | 2020-09-10 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | 0.33 |
| Report Date: | 2020-05-26 |
| Date: | 2020-03-31 |
| Before After Market: | Before Market |
| Currency: | PLN |
| Eps Actual: | 0.21 |
| Date: | 2024-06-30 |
| Eps Actual: | -0.66 |
| Date: | 2023-12-31 |
| Eps Actual: | 3.80 |
| Date: | 2022-12-31 |
| Eps Actual: | 1.65 |
| Date: | 2021-12-31 |
| Eps Actual: | 0.81 |
| Date: | 2020-12-31 |
| Eps Actual: | 1.04 |